What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update
DJ Langford, R Baron, RR Edwards, JS Gewandter… - Pain, 2023 - journals.lww.com
Pharmacological treatments for chronic pain are limited in options and effectiveness, 29 with
only about half of patients experiencing a 30% reduction in pain intensity. 25 In light of …
only about half of patients experiencing a 30% reduction in pain intensity. 25 In light of …
[HTML][HTML] Critical NIH resources to advance therapies for pain: preclinical screening program and phase II human clinical trial network
S Iyengar, SA Woller, R Hommer, J Beierlein… - …, 2020 - Elsevier
Opioid-related death and overdose have now reached epidemic proportions. In response to
this public health crisis, the National Institutes of Health (NIH) launched the Helping to End …
this public health crisis, the National Institutes of Health (NIH) launched the Helping to End …
New concepts in opioid analgesia
C Stein - Expert opinion on investigational drugs, 2018 - Taylor & Francis
Introduction: Opioids are the oldest and most potent drugs for the treatment of severe pain,
but they are burdened by detrimental side effects such as respiratory depression, addiction …
but they are burdened by detrimental side effects such as respiratory depression, addiction …
[PDF][PDF] Opioid receptors in analgesic drug design–the past, present and future
AS Yekkirala - J. of Postdoctoral Research, 2013 - postdocjournal.com
Pain is a common phenomenon that is expressed due to external tissue injury or innate
physiological dysfunction. While everyone has experienced pain in some form or the other …
physiological dysfunction. While everyone has experienced pain in some form or the other …
Topical reviews: a new type of report inPAIN
GF Gebhart - Pain, 1992 - journals.lww.com
The review by Tallarida in this issue is noteworthy for two reasons. It marks the first of a new
type of review for the journal. We all have benefited from the careful and thorough major …
type of review for the journal. We all have benefited from the careful and thorough major …
New treatments for neuropathic pain
Existing treatments for neuropathic pain deliver inadequate pain relief, unacceptable side
effects, or both. The unmet medical need for more effective treatment is driving a large …
effects, or both. The unmet medical need for more effective treatment is driving a large …
Challenges in analgesic drug development
DJ Hewitt, RJ Hargreaves, SP Curtis… - Clinical …, 2009 - Wiley Online Library
As many as 50 million people in the United States suffer from chronic pain. 1 Our most
effective analgesics—including opioids, nonsteroidal anti‐inflammatory drugs …
effective analgesics—including opioids, nonsteroidal anti‐inflammatory drugs …
The opioid crisis and the future of addiction and pain therapeutics
NP Coussens, GS Sittampalam, SG Jonson… - Journal of pharmacology …, 2019 - ASPET
Opioid misuse and addiction are a public health crisis resulting in debilitation, deaths, and
significant social and economic impact. Curbing this crisis requires collaboration among …
significant social and economic impact. Curbing this crisis requires collaboration among …
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
Pain medication plays an important role in the treatment of acute and chronic pain
conditions, but some drugs, opioids in particular, have been overprescribed or prescribed …
conditions, but some drugs, opioids in particular, have been overprescribed or prescribed …
[图书][B] The essence of analgesia and analgesics
RS Sinatra, JS Jahr, JM Watkins-Pitchford - 2010 - books.google.com
The Essence of Analgesia and Analgesics is an invaluable practical resource for clinicians
giving pain relief in any clinical setting, describing the pharmacologic principles and clinical …
giving pain relief in any clinical setting, describing the pharmacologic principles and clinical …